05.07.26 -- Lilly's Unified Mindset For A Global Parenteral And Device Manufacturing Network

PolyA tail stability shapes mRNA potency, consistency, and manufacturability. Addressing integrity early reduces variability, simplifies workflows, and supports reliable clinical scale‑out.

Explore how tubular bowl centrifuges improve media exchange during induced pluripotent stem cell cultivation. This application supports more efficient workflows for regenerative medicine scale-up.

N-1 perfusion enables higher inoculum densities, faster production, and reduced costs without altering fed-batch processes. Uncover this practical path to intensification for biologics manufacturers.

Conventional electroporation methods struggle with damaging heat buildup. Discover how innovative flow technology leverages physics to protect cells and enable large-scale therapeutic production.

Analyze how TMP and permeate control strategies impact flux and impurity removal during viral vector processing. Understanding these variables ensures more predictable scale-up across development.

Digital twin technology optimizes aseptic fill-finish through real-time mirroring and predictive simulation. Improve yields and validate complex recipes by integrating dynamic virtual models.

Study the development and performance of this animal origin-free (AOF) T cell culture medium designed for T cell expansion through an experiment comparing it to other AOF or xeno-free basal offerings.

From donor variability to collection site inconsistencies, cell and gene therapy faces raw material challenges. Ensuring stable, high-quality leukopaks is vital for effective treatments.

Syngeneic mouse tumor models are crucial for immunotherapy research, but variability in TILs and nonspecific binding complicate analysis. See how blocking reagents help but make the process more labor-intensive.